Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression
Author:
Publisher
Elsevier BV
Subject
Cell Biology
Reference41 articles.
1. Cell signaling and cancer;Martin;Cancer Cell,2003
2. The PI3K inhibitor arsenal: choose your weapon!;Crabbe;Trends Biochem. Sci.,2007
3. Targeting the phosphoinositide 3-kinase pathway in cancer;Liu;Nat. Rev. Drug Discov.,2009
4. Exploiting the PI3K/AKT pathway for cancer drug discovery;Hennessy;Nat. Rev. Drug Discov.,2005
5. PI3K in lymphocyte development, differentiation and activation;Okkenhaug;Nat. Rev. Immunol.,2003
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway;American Journal of Cancer Research;2024
2. Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment;Current Topics in Medicinal Chemistry;2023-12
3. Stem cell-based therapies for heart failure management: a narrative review of current evidence and future perspectives;Heart Failure Reviews;2023-09-21
4. Curcumin-Coated Poly(lactic-co-glycolic acid) Nanoparticles Affect Colorectal Cancer Cells Growth by Regulating Notch Signaling Pathway;Science of Advanced Materials;2022-04-01
5. Personalised Medicine for Colorectal Cancer Using Mechanism-Based Machine Learning Models;International Journal of Molecular Sciences;2021-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3